Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, et al. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 2024;132(7):396-418.

Furtado LV, Bifulco C, Dolderer D, Hsiao SJ, Kipp BR, Lindeman NI, et al. Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer. J Mol Diagn. 2024;26(8):653-668.

Long ME, Koirala S, Sloan S, Brown-Burke F, Weigel C, Villagomez L, et al. Resistance to PRMT5-targeted therapy in mantle cell lymphoma. Blood Adv. 2024;8(1):150-163.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

Deochand DK, Dacic M, Bale MJ, Daman AW, Josefowicz SZ, Oliver D, et al. Mechanisms of Epigenomic and Functional Convergence Between Glucocorticoid- and IL4-Driven Macrophage Programming. bioRxiv. 2024.

Javdan B, Marwaha S, Magro C, Wassef C. Pink Papules on the Cheek. Cutis. 2024;113(1):10-17.

Solomon JP, Munoz-Zuluaga C, Slocum C, Dillard A, Cong L, Wang J, et al. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples. Diagn Pathol. 2024;19(1):70.

Christakis A, Nowak J, Hamilton MJ, Goldblum JR, Parrack P, Lindeman NI, et al. Molecular profiling of visible polypoid and invisible conventional intestinal-type low-grade dysplasia in patients with idiopathic inflammatory bowel disease. J Clin Pathol. 2024.

Solomon JP. Practical Considerations for Oncogenic Fusion Detection and Reporting in Solid Tumors. J Appl Lab Med. 2024;9(1):116-123.

Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis. Circ Res. 2024.